Figure 8.
The schematic diagram of L. acidophilus ameliorating cholestatic liver injury. L. acidophilus inhibits hepatic BAs synthesis by activating intestinal FXR signaling, and increases unconjugated BAs by enriched BSH enzymes to enhance the BAs excretion, which could attenuate cholestatic liver injury.